Kaken Pharmaceutical Co., Ltd.

Kaken Pharmaceutical Co., Ltd.verified

KKPCF

Price:

$24

Market Cap:

$142.39B

Kaken Pharmaceutical Co., Ltd. produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally. It offers pharmaceutical products and medical devices, such as Clenafin, a topical treatment for onychomycosis; Artz, an anti-osteoarthritis agent; Seprafilm, a semitransparent film-type absorbable adhesion barrier, which is applied to damaged tissue; Fiblast, a spray-on drug for the treatment of pressure ulcers and other skin ulcers; Regroth, a medicinal product for periodontal regeneration; and Hernicore for the treatment of lumbar disc herniation. The company also provides Adofeed, a pain- and inflammation-relieving plaster; Ebrantil for the treatm...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2020-12-09

Stock Exchange

OTC

Ticker

KKPCF

The ROE as of December 2025 (TTM) for Kaken Pharmaceutical Co., Ltd. (KKPCF) is 8.18%

According to Kaken Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 8.18%. This represents a change of 307.61% compared to the average of 2.01% of the last 4 quarters.

Kaken Pharmaceutical Co., Ltd. (KKPCF) Historical ROE (quarterly & annually)

How has KKPCF ROE performed in the past?

The mean historical ROE of Kaken Pharmaceutical Co., Ltd. over the last ten years is 12.69%. The current 8.18% ROE has changed -35.59% with respect to the historical average. Over the past ten years (40 quarters), KKPCF's ROE was at its highest in in the December 2015 quarter at 8.30%. The ROE was at its lowest in in the March 2025 quarter at -3.43%.

Quarterly (TTM)
Annual

Average

12.69%

Median

12.26%

Minimum

3.99%

Maximum

23.53%

Kaken Pharmaceutical Co., Ltd. (KKPCF) ROE by Quarter and Year

Discovering the peaks and valleys of Kaken Pharmaceutical Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 63.66%

Maximum Annual ROE = 23.53%

Minimum Annual Increase = -42.41%

Minimum Annual ROE = 3.99%

Quarterly (TTM)
Annual
YearROEChange
20259.14%63.66%
20245.58%39.82%
20233.99%-42.41%
20226.93%-29.54%
20219.84%-34.75%
202015.08%2.75%
201914.67%-12.25%
201816.72%-22.03%
201721.45%-8.83%
201623.53%49.62%

Kaken Pharmaceutical Co., Ltd. (KKPCF) Average ROE

How has KKPCF ROE performed in the past?

The current ROE of Kaken Pharmaceutical Co., Ltd. (KKPCF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

6.24%

5-year avg

7.10%

10-year avg

12.69%

Kaken Pharmaceutical Co., Ltd. (KKPCF) ROE vs. Peers

How is KKPCF’s ROE compared to its peers?

Kaken Pharmaceutical Co., Ltd.’s ROE is less than Luye Pharma Group Ltd. (2.75%), less than China Shineway Pharmaceutical Group Limited (10.84%), less than Adcock Ingram Holdings Limited (15.09%), less than Drägerwerk AG & Co. KGaA (6.70%), greater than TerrAscend Corp. (-70.88%), less than PT Tempo Scan Pacific Tbk (15.11%), greater than Biotest AG (-4.66%), less than Kossan Rubber Industries Bhd (3.34%), less than Columbia Care Inc. (42.28%), less than Biotage AB (publ) (6.58%),

Build a custom stock screener for Kaken Pharmaceutical Co., Ltd. (KKPCF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kaken Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kaken Pharmaceutical Co., Ltd. (KKPCF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kaken Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Kaken Pharmaceutical Co., Ltd.'s ROE?

How is the ROE calculated for Kaken Pharmaceutical Co., Ltd. (KKPCF)?

What is the highest ROE for Kaken Pharmaceutical Co., Ltd. (KKPCF)?

What is the 3-year average ROE for Kaken Pharmaceutical Co., Ltd. (KKPCF)?

What is the 5-year average ROE for Kaken Pharmaceutical Co., Ltd. (KKPCF)?

How does the current ROE for Kaken Pharmaceutical Co., Ltd. (KKPCF) compare to its historical average?